<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Are all beta-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension

Thumbnail Image

Departments

OrgUnit Logo
Item type:Organizational Unit,

School / College / Institute

OrgUnit Logo
Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU-Authors

Organization Authors

Co-Authors

Afsar, Baris

Date

2015

Language

Type

Other

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension

Abstract

Source

Publisher

Wiley

Subject

Antihypertensive therapy , Beta-blocker pharmacology , Vascular function

Citation

item.page.haspartof

Source

Journal Of Clinical Hypertension

item.page.ispartofseries

item.page.edition

DOI

10.1111/jch.12447

URI

https://doi.org/10.1111/jch.12447
 https://hdl.handle.net/20.500.14288/10351

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Collections

Publications without Fulltext

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Thumbnail Image
Item type:Goal, Access status: Open Access ,
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.
Google Scholar
Scholar'da Ara ↗
1
Görüntülenme
0
İndirme
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators